Abstract

Iron deficiency is the most prevalent micronutrient disorder globally. When severe, iron deficiency leads to anemia, which can be deleterious to cardiac function. Given the central role of iron and oxygen in cardiac biology, multiple pathways are expected to be altered in iron-deficiency anemia, and identifying these requires an unbiased approach. To investigate these changes, gene expression and metabolism were studied in mice weaned onto an iron-deficient diet for 6 weeks. Whole-exome transcriptomics (RNAseq) identified over 1,500 differentially expressed genes (DEGs), of which 22% were upregulated and 78% were downregulated in the iron-deficient group, relative to control animals on an iron-adjusted diet. The major biological pathways affected were oxidative phosphorylation and pyruvate metabolism, as well as cardiac contraction and responses related to environmental stress. Cardiac metabolism was studied functionally using in vitro and in vivo methodologies. Spectrometric measurement of the activity of the four electron transport chain complexes in total cardiac lysates showed that the activities of Complexes I and IV were reduced in the hearts of iron-deficient animals. Pyruvate metabolism was assessed in vivo using hyperpolarized 13C magnetic resonance spectroscopy (MRS) of hyperpolarized pyruvate. Hearts from iron-deficient and anemic animals showed significantly decreased flux through pyruvate dehydrogenase and increased lactic acid production, consistent with tissue hypoxia and induction of genes coding for glycolytic enzymes and H+-monocarboxylate transport-4. Our results show that iron-deficiency anemia results in a metabolic remodeling toward a glycolytic, lactic acid-producing phenotype, a hallmark of hypoxia.

Highlights

  • Iron deficiency is a common comorbidity in chronic heart failure and is demonstrably associated with higher mortality rates [1,2,3]

  • Its most important finding is that Iron-Deficiency Anemia anemia (IDA) engenders a hypoxia-like glycolytic shift in cardiac metabolism

  • This finding is of significance because it describes a direct mechanism that can explain at least part of the detrimental consequences of IDA in heart failure patients

Read more

Summary

Introduction

Iron deficiency is a common comorbidity in chronic heart failure and is demonstrably associated with higher mortality rates [1,2,3]. Severe iron deficiency leads to anemia, and there is growing evidence that impaired oxygen transport contributes to cardiac disease and death [7,8,9]. An elevated glycolytic rate will lead to an enhanced production of lactic acid [13], potentially reducing intracellular pH (pHi), a major modulator of cardiac function [14, 15]. In addition to a metabolic effect, iron-deficiency anemia may alter cardiac gene expression through oxygen- and iron-sensitive enzymes such as prolyl hydroxylases (PHDs) and lysine demethylases (KDMs), which regulate the transcription factor hypoxia inducible factor (HIF) [16, 17] and histone methylation mark [18,19,20], respectively. To gain unbiased insight into the possible changes in cardiac function under IDA, a non-candidate approach is warranted

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call